These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28978795)

  • 1. DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling.
    Singh AK; Eken A; Hagin D; Komal K; Bhise G; Shaji A; Arkatkar T; Jackson SW; Bettelli E; Torgerson TR; Oukka M
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.
    Janssen E; Kumari S; Tohme M; Ullas S; Barrera V; Tas JM; Castillo-Rama M; Bronson RT; Usmani SM; Irvine DJ; Mempel TR; Geha RS
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells.
    Janssen E; Morbach H; Ullas S; Bannock JM; Massad C; Menard L; Barlan I; Lefranc G; Su H; Dasouki M; Al-Herz W; Keles S; Chatila T; Geha RS; Meffre E
    J Allergy Clin Immunol; 2014 Dec; 134(6):1365-1374. PubMed ID: 25218284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOCK8 Expression in Regulatory T Cells Maintains their Stability and Limits Contact Hypersensitivity.
    Wilkie H; Janssen E; Leyva-Castillo JM; Geha RS
    J Invest Dermatol; 2021 Jun; 141(6):1503-1511.e3. PubMed ID: 33171169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiency.
    Wilkie H; Das M; Pelovitz T; Bainter W; Woods B; Alasharee M; Sobh A; Baris S; Eltan SB; Al-Herz W; Barbouche MR; Ben-Mustapha I; Ben-Ali M; Sallam MTH; Awad A; Lotfy S; El Marsafy A; Ezzelarab M; Farrar M; Schmidt BAR; NandyMazumdar M; Guttman-Yassky E; Sheets A; Vidic KM; Murphy G; Schlievert PM; Chou J; Leyva-Castillo JM; Janssen E; Timilshina M; Geha RS
    J Allergy Clin Immunol; 2024 Jul; 154(1):143-156. PubMed ID: 38185418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance.
    Dikiy S; Li J; Bai L; Jiang M; Janke L; Zong X; Hao X; Hoyos B; Wang ZM; Xu B; Fan Y; Rudensky AY; Feng Y
    Immunity; 2021 May; 54(5):931-946.e11. PubMed ID: 33838102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOCK8: regulator of Treg in response to corticotropin-releasing hormone.
    Jin S; Shin JU; Noh JY; Kim H; Kim JY; Kim SH; Kim JH; Park CO; Lee N; Lee H; Lee JS; Lee KH
    Allergy; 2016 Jun; 71(6):811-9. PubMed ID: 26799599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
    Shi H; Liu C; Tan H; Li Y; Nguyen TM; Dhungana Y; Guy C; Vogel P; Neale G; Rankin S; Feng Y; Peng J; Tao W; Chi H
    Immunity; 2018 Nov; 49(5):899-914.e6. PubMed ID: 30413360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity.
    Muto G; Kotani H; Kondo T; Morita R; Tsuruta S; Kobayashi T; Luche H; Fehling HJ; Walsh M; Choi Y; Yoshimura A
    PLoS One; 2013; 8(9):e74639. PubMed ID: 24058613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
    Biggs CM; Keles S; Chatila TA
    Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.
    Chen X; Priatel JJ; Chow MT; Teh HS
    J Immunol; 2008 May; 180(9):5973-82. PubMed ID: 18424717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOCK8 Deficiency Presenting as an IPEX-Like Disorder.
    Alroqi FJ; Charbonnier LM; Keles S; Ghandour F; Mouawad P; Sabouneh R; Mohammed R; Almutairi A; Chou J; Massaad MJ; Geha RS; Baz Z; Chatila TA
    J Clin Immunol; 2017 Nov; 37(8):811-819. PubMed ID: 29058101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
    Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
    J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.
    Garg G; Tyler JR; Yang JH; Cutler AJ; Downes K; Pekalski M; Bell GL; Nutland S; Peakman M; Todd JA; Wicker LS; Tree TI
    J Immunol; 2012 May; 188(9):4644-53. PubMed ID: 22461703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD83 expression is essential for Treg cell differentiation and stability.
    Doebbeler M; Koenig C; Krzyzak L; Seitz C; Wild A; Ulas T; Baßler K; Kopelyanskiy D; Butterhof A; Kuhnt C; Kreiser S; Stich L; Zinser E; Knippertz I; Wirtz S; Riegel C; Hoffmann P; Edinger M; Nitschke L; Winkler T; Schultze JL; Steinkasserer A; Lechmann M
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.